Riskpilot← Back to searchSign inGet full accessMAURA LEGESENTER AS
ASActiveOrg 917811032Mauravegen 4, 2032 MauraGeneral medical practice activities · NACE 8621Est. 20165 employees
Revenue 2024
NOK 3,7M
+6% vs 2023
EBITDA margin
1.2%
+23% vs 2023
Equity ratio
31.1%
Financial strength
Net profit 2024
NOK 23K
+1168% vs 2023
| Revenue | NOK 3,7M | +6% |
| EBITDA | NOK 43K | +23% |
| Net profit | NOK 23K | +1168% |
| Total assets | NOK 637K | +50% |
| Equity | NOK 198K | +13% |
| Employees | 5 | — |
Legal name
MAURA LEGESENTER AS
Org number
917811032
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
30. september 2016
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Legesenter innen allmenn legetjeneste, investering og deltakelse i eiendom og andre selskaper, samt alt annet som naturlig faller inn under dette.
Address
Mauravegen 4, 2032 Maura
Phone
+4763993797
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 128 | 2 924 | 3 489 | 3 468 | 3 691 |
| Staff expenses | −1 000 | −798 | −1 196 | −1 358 | −1 410 |
| EBITDA | 192 | −24 | 167 | 35 | 43 |
| Depreciation & amort. | −41 | −45 | −34 | −32 | −10 |
| EBIT | 151 | −69 | 133 | 2 | 33 |
| Net financials | 0 | 0 | −1 | −0 | −1 |
| Profit before tax | 151 | −69 | 132 | 2 | 32 |
| Tax | 29 | −0 | 18 | 5 | 9 |
| Net profit | 122 | −69 | 115 | −2 | 23 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 335 | 284 | 455 | 426 | 637 |
| Equity | 131 | 62 | 177 | 175 | 198 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 203 | 222 | 279 | 252 | 439 |
| Total debt | 203 | 222 | 279 | 252 | 439 |
EBITDA margin
1.2%
This company
15.8%
Market median
-92% vs market
20202024
Equity ratio
31.1%
This company
38.2%
Market median
+19% vs market
20202024
Return on equity
11.8%
This company
18.4%
Market median
+36% vs market
20202024
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
20202024
Asset turnover
5.79×
This company
1.12×
Market median
+417% vs market
20202024
Debt / equity
2.22×
This company
0.62×
Market median
-258% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Former (4) | ||
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2023 – 2025 | |
| Chairman | 2021 – 2023 | |
| Board of Directors | 2023 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MAURA LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anja Langerud | Board of Directors | 0 companies |
| Christoffer Landfald Sandvik | Board of Directors | 0 companies |
| Maymunah Ghulam | Board of Directors | 0 companies |
| Seyed Mohsen Miryahyaei | Chairman | 0 companies |
| Anja Lefstad | Board of Directors | 0 companies |
| Irfan Sharif Shakoori | Board of Directors | 0 companies |
| Seyed Ebrahim Alavi | Chairman | 0 companies |
| Ole Marius Gaasø | Board of Directors | 0 companies |